We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA (HCA) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
Analysts on Wall Street project that HCA Healthcare (HCA - Free Report) will announce quarterly earnings of $5.02 per share in its forthcoming report, representing an increase of 8.2% year over year. Revenues are projected to reach $16.55 billion, increasing 6.8% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Bearing this in mind, let's now explore the average estimates of specific HCA metrics that are commonly monitored and projected by Wall Street analysts.
Analysts predict that the 'Revenue per Equivalent Admission' will reach $17,197.66. The estimate compares to the year-ago value of $16,628.
Analysts forecast 'Equivalent Admissions' to reach 965.36 million. Compared to the current estimate, the company reported 931.99 million in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Number of hospitals' of 183. Compared to the present estimate, the company reported 182 in the same quarter last year.
The consensus among analysts is that 'Equivalent Patient Days' will reach 4,717.14 thousand. Compared to the current estimate, the company reported 4,655.84 thousand in the same quarter of the previous year.
Analysts expect 'Admissions' to come in at 543.26 million. The estimate compares to the year-ago value of 530.3 million.
It is projected by analysts that the 'Licensed Beds at End of Period' will reach 49,292. The estimate compares to the year-ago value of 49,281.
The average prediction of analysts places 'Patient Days' at 2,613.57 Days. The estimate compares to the year-ago value of 2,648.68 Days.
Shares of HCA have demonstrated returns of +2.8% over the past month compared to the Zacks S&P 500 composite's +2.5% change. With a Zacks Rank #2 (Buy), HCA is expected to beat the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
HCA (HCA) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Analysts on Wall Street project that HCA Healthcare (HCA - Free Report) will announce quarterly earnings of $5.02 per share in its forthcoming report, representing an increase of 8.2% year over year. Revenues are projected to reach $16.55 billion, increasing 6.8% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Bearing this in mind, let's now explore the average estimates of specific HCA metrics that are commonly monitored and projected by Wall Street analysts.
Analysts predict that the 'Revenue per Equivalent Admission' will reach $17,197.66. The estimate compares to the year-ago value of $16,628.
Analysts forecast 'Equivalent Admissions' to reach 965.36 million. Compared to the current estimate, the company reported 931.99 million in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Number of hospitals' of 183. Compared to the present estimate, the company reported 182 in the same quarter last year.
The consensus among analysts is that 'Equivalent Patient Days' will reach 4,717.14 thousand. Compared to the current estimate, the company reported 4,655.84 thousand in the same quarter of the previous year.
Analysts expect 'Admissions' to come in at 543.26 million. The estimate compares to the year-ago value of 530.3 million.
It is projected by analysts that the 'Licensed Beds at End of Period' will reach 49,292. The estimate compares to the year-ago value of 49,281.
The average prediction of analysts places 'Patient Days' at 2,613.57 Days. The estimate compares to the year-ago value of 2,648.68 Days.
View all Key Company Metrics for HCA here>>>
Shares of HCA have demonstrated returns of +2.8% over the past month compared to the Zacks S&P 500 composite's +2.5% change. With a Zacks Rank #2 (Buy), HCA is expected to beat the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>